Waltham biotech raises $336M for new Covid-19 drug

Alongside mainstream vaccine developers such as Pfizer-BioNTech and Moderna Inc., a local biotech has made progress in coronavirus vaccines and treatments of its own — and plans to use its latest fundraise to advance its lead drug, which is being developed to work both as treatment and prevention therapy.